packageAvacincaptadPegol

avacincaptad pegol

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Avacincaptad pegol is an eye medication developed for macular degeneration, specifically geographic atrophy. It is approved in the United States but remains investigational in Europe, where a marketing application was withdrawn.

Summary written by glm-5.3-flash from Wikidata Q121945069 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:avacincaptad pegol
ATC codes:S01XA32
DrugBank:DB15165
Wikidata:Q121945069

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown